annual accounts payable:
$72.00M+$31.32M(+76.99%)Summary
- As of today (May 30, 2025), AXSM annual accounts payable is $72.00 million, with the most recent change of +$31.32 million (+76.99%) on December 31, 2024.
- During the last 3 years, AXSM annual accounts payable has risen by +$58.85 million (+447.53%).
- AXSM annual accounts payable is now at all-time high.
Performance
AXSM Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$85.66M+$13.66M(+18.98%)Summary
- As of today (May 30, 2025), AXSM quarterly accounts payable is $85.66 million, with the most recent change of +$13.66 million (+18.98%) on March 31, 2025.
- Over the past year, AXSM quarterly accounts payable has increased by +$31.87 million (+59.24%).
- AXSM quarterly accounts payable is now at all-time high.
Performance
AXSM quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AXSM Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +77.0% | +59.2% |
| 3 y3 years | +447.5% | +580.1% |
| 5 y5 years | +557.9% | +602.6% |
AXSM Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +447.5% | at high | +580.1% |
| 5 y | 5-year | at high | +557.9% | at high | +814.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
AXSM Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $85.66M(+19.0%) |
| Dec 2024 | $72.00M(+77.0%) | $72.00M(+12.1%) |
| Sep 2024 | - | $64.25M(+4.7%) |
| Jun 2024 | - | $61.34M(+14.0%) |
| Mar 2024 | - | $53.79M(+32.2%) |
| Dec 2023 | $40.68M(+5.4%) | $40.68M(+39.8%) |
| Sep 2023 | - | $29.10M(-32.3%) |
| Jun 2023 | - | $42.96M(+20.1%) |
| Mar 2023 | - | $35.77M(-7.3%) |
| Dec 2022 | $38.60M(+193.6%) | $38.60M(+200.6%) |
| Sep 2022 | - | $12.84M(-33.9%) |
| Jun 2022 | - | $19.43M(+54.3%) |
| Mar 2022 | - | $12.60M(-4.2%) |
| Dec 2021 | $13.15M(-2.6%) | $13.15M(-1.7%) |
| Sep 2021 | - | $13.38M(+15.2%) |
| Jun 2021 | - | $11.61M(-20.6%) |
| Mar 2021 | - | $14.62M(+8.3%) |
| Dec 2020 | $13.50M(+23.4%) | $13.50M(+19.3%) |
| Sep 2020 | - | $11.32M(+20.8%) |
| Jun 2020 | - | $9.36M(-23.2%) |
| Mar 2020 | - | $12.19M(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $10.94M(+196.8%) | $10.94M(+15.8%) |
| Sep 2019 | - | $9.45M(+53.9%) |
| Jun 2019 | - | $6.14M(+78.7%) |
| Mar 2019 | - | $3.43M(-6.9%) |
| Dec 2018 | $3.69M(+7.3%) | $3.69M(-11.5%) |
| Sep 2018 | - | $4.17M(+31.2%) |
| Jun 2018 | - | $3.18M(-18.1%) |
| Mar 2018 | - | $3.87M(+12.8%) |
| Dec 2017 | $3.44M(-15.8%) | $3.44M(+16.7%) |
| Sep 2017 | - | $2.94M(-27.1%) |
| Jun 2017 | - | $4.04M(-14.8%) |
| Mar 2017 | - | $4.74M(+16.2%) |
| Dec 2016 | $4.08M(+115.7%) | $4.08M(+5.5%) |
| Sep 2016 | - | $3.87M(+27.4%) |
| Jun 2016 | - | $3.04M(+65.8%) |
| Mar 2016 | - | $1.83M(-3.3%) |
| Dec 2015 | $1.89M(+149.6%) | $1.89M(+10.3%) |
| Sep 2015 | - | $1.72M(+59.7%) |
| Jun 2015 | - | $1.07M(+41.7%) |
| Dec 2014 | $758.20K(+376.0%) | $758.20K |
| Dec 2013 | $159.30K | - |
FAQ
- What is Axsome Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Axsome Therapeutics?
- What is Axsome Therapeutics annual accounts payable year-on-year change?
- What is Axsome Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly accounts payable year-on-year change?
What is Axsome Therapeutics annual accounts payable?
The current annual accounts payable of AXSM is $72.00M
What is the all time high annual accounts payable for Axsome Therapeutics?
Axsome Therapeutics all-time high annual accounts payable is $72.00M
What is Axsome Therapeutics annual accounts payable year-on-year change?
Over the past year, AXSM annual accounts payable has changed by +$31.32M (+76.99%)
What is Axsome Therapeutics quarterly accounts payable?
The current quarterly accounts payable of AXSM is $85.66M
What is the all time high quarterly accounts payable for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly accounts payable is $85.66M
What is Axsome Therapeutics quarterly accounts payable year-on-year change?
Over the past year, AXSM quarterly accounts payable has changed by +$31.87M (+59.24%)